ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 102 of 179 for:    "Arthritis, Juvenile Rheumatoid"

"Medikidz Explain JIA Comic Book- Hebrew"

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02191722
Recruitment Status : Completed
First Posted : July 16, 2014
Last Update Posted : May 10, 2016
Sponsor:
Information provided by (Responsible Party):
GIL AMARILYO, Rabin Medical Center

Brief Summary:
We believe, that the results of this study will show that children learn from the comic book about their disease, and are now more aware and less frightened about it, and increase their compliance.

Condition or disease Intervention/treatment Phase
Juvenile Idiopathic Arthritis Behavioral: reading comics booklet Not Applicable

Detailed Description:
We believe, that the results of this study will show that children learn from the comic book about their disease, and are now more aware and less frightened about it, and increase their compliance. If so, it may promote the use of comic books or other fun educational tool in teaching children various other diseases.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 4 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Evaluating the Efficacy of a Comic Book as an Educating Tool for Children With Juvenile Idiopathic Arthritis
Study Start Date : August 2014
Actual Primary Completion Date : May 2016
Actual Study Completion Date : May 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: JIA patients
All participants will be evaluated before and after reading the comics booklet
Behavioral: reading comics booklet



Primary Outcome Measures :
  1. 30% or more improvement in a knowledge questionnaire (before and after reading the comics booklet) [ Time Frame: 2 Years ]

Secondary Outcome Measures :
  1. 10% or higher score in CHQ questionnaire (after reading the comics booklet) [ Time Frame: 2 Years ]
  2. better compliance ( >1 score improvement in 1-5 scale score, as evaluated by the physician after reading the comics booklet). [ Time Frame: 2 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   10 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Children with JIA aged 10-18 after parents signed ICF

Exclusion Criteria:

Parents that do not wanf their children to participate in the study.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02191722


Locations
Israel
SCMCI
Petah-Tikva, 14 Kaplan s., Israel
Sponsors and Collaborators
Rabin Medical Center
Investigators
Principal Investigator: Gil Amarilyo, MD Schneider Children Medical Center of Israel

Publications:
Responsible Party: GIL AMARILYO, MD, Rabin Medical Center
ClinicalTrials.gov Identifier: NCT02191722     History of Changes
Other Study ID Numbers: 0213-14-RMC
First Posted: July 16, 2014    Key Record Dates
Last Update Posted: May 10, 2016
Last Verified: May 2016

Additional relevant MeSH terms:
Arthritis
Arthritis, Juvenile
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases